Search Results for: Any combination instruments
renee hansen pleasanton, ca, september rd, . astex pharmaceuticals, inc., a wholly owned subsidiary of otsuka pharmaceutical co. ltd., based in tokyo, japan, announces that the us food & drug administration (fda) has granted orphan drug designation for the company's orally administered fixed-dose combination
"we are delighted that the fda has granted orphan drug designation for the fixed dose combination of cedazuridine with decitabine," said mohammad azab, md, astex pharmaceuticals' president and chief medical officer....
https://astx.com/astex-pharmaceuticals-announces-that-its-novel-oral-hypomethylating-agent-astx727-has-been-granted-orphan-drug-designation-for-the-treatment-of-myelodysplastic-syndromes-including-chronic-myelomonoc/